News – Page 371 – Endpoints News

Publicis Health aims to sort pharma marketing data with new advisory and insights business

3 years ago

US spent nearly $32B in public funds on mRNA vaccine development, study finds

3 years ago

Senate health committee chair demands Novo, Sanofi drop insulin costs after Lilly

3 years ago

Canadian CDMO AtomVie, armed with $40M Series A, readies new manufacturing facility

3 years ago

Manufacturing roundup: Actylis opens the doors to a facility in Oregon; Emergent reports Q4 numbers

3 years ago

BioNTech to expand presence in Israel with manufacturing and research site

3 years ago

Intellia gets FDA clearance to start hereditary angioedema gene editing trial in US

3 years ago

Valneva reports more data on Covid-19 vaccine; ClinChoice buys a CRO

3 years ago

Shanghai's Abbisko out-licenses EGFR candidate in potentially nine-figure deal

3 years ago

'You are not the drug sponsor': FDA declines petition to anoint Cassava's drug as 'breakthrough'

3 years ago

FDA schedules advisory committee hearing for Lynparza prostate cancer application

3 years ago

Akorn Pharmaceuticals files for bankruptcy, closes facilities and will liquidate

3 years ago

FDA adopts ICH guidance on continuous manufacturing

3 years ago

Dynacure to merge with Flamingo, rejoining two Ionis-affiliated biotechs

3 years ago

Tech, commerce-focused investor unveils $500M bet on healthcare

3 years ago

MorphoSys chops back again, this time cutting preclinical efforts in late-stage push

3 years ago

Scoop: Ascletis' NASH subsidiary scraps US PhII trial in favor of China

3 years ago

Novo Nordisk touts expansion in Boston, cuts about 100 jobs in two other US cities

3 years ago

Novo Nordisk offloads preclinical cancer candidate from $1.1B Forma buyout

3 years ago

Eli Lilly licenses early-stage non-opioid pain drug from Belgian biotech Confo

3 years ago

Two for two: GSK follows Pfizer, secures adcomm thumbs-up for RSV vaccine in older adults

3 years ago

Q&A: Fujifilm Diosynth CEO Martin Meeson says company is in 'growth mode'

3 years ago

Ionis introduces young 'rising star' scientists, sharing research projects and passions on new podcast

3 years ago

CBER director Peter Marks says FDA is growing to keep up with cell and gene therapies

3 years ago

First page Previous page 368 369 370371372 373 374 Next page Last page